(SERA) – Globe Newswire
-
Sera Prognostics Appoints Dr. Paul Kearney as Chief Data Officer
-
Sera Prognostics Appoints Dr. Paul Kearney as Chief Data Officer
-
Sera Prognostics to be Added to Russell 2000 Index
-
Sera Prognostics to be Added to Russell 2000 Index
-
Sera Prognostics Appoints Dr. Michael R. Foley as Chief Medical Officer
-
Sera Prognostics Appoints Dr. Michael R. Foley as Chief Medical Officer
-
Sera Prognostics Announces Publication of Health Economic Analysis Supporting PreTRM® Test-and-Treat Strategy to Improve Maternal and Infant Health
-
Sera Prognostics to Present at Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit
-
Sera Prognostics to Present at Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit
-
Sera Prognostics Reports Second Quarter 2021 Financial Results
-
Sera Prognostics Reports Second Quarter 2021 Financial Results
-
Sera Prognostics’ PreTRM® Test and Treat Strategy Benefits Demonstrated by Results of Prospective, Randomized Controlled Intervention Trial Evaluating Clinical Utility
-
Sera Prognostics Announces Pricing of Initial Public Offering
Back to SERA Stock Lookup